Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

MaxCyte Inc (MXCT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
310.00 -5.00    -1.59%
08:12:14 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 91
  • Bid/Ask: 310.00 / 320.00
  • Day's Range: 310.00 - 310.00
Type:  Equity
Market:  United Kingdom
ISIN:  US57777K1060 
SEDOL:  BYVJZ42
MaxCyte 310.00 -5.00 -1.59%

MaxCyte Company Profile

 
Read the MaxCyte Inc company profile to learn more about the business and the management team. View MaxCyte Inc facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

125

Equity Type

ORD

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Contact Information

Address 9713 Key West Avenue Suite 400
Rockville, 20850
United States
Phone 301 944 1700
Fax -

Top Executives

Name Age Since Title
Richard Huntington Douglas 69 2018 Independent Non-Executive Chairman of the Board
William W. Brooke 67 2004 Independent Non-Executive Director
Arthur Michael Mandell 71 2006 Independent Non-Executive Director
Stanley Charles Erck 76 2005 Independent Non-Executive Director
John Joseph Johnston 65 2016 Independent Non-Executive Director
Rekha Hemrajani 55 2021 Independent Non-Executive Director
Yasir B. Al-Wakeel 42 2021 Independent Non-Executive Director
Maher Masoud 48 2017 President, CEO, Secretary & Director
Cenk Sumen 50 2022 Member of Scientific Advisory Board
Nako Nakatsuka - 2023 Member of Scientific Advisory Board
Oliver Rando - 2023 Member of Scientific Advisory Board
Patrick J. Balthrop 67 2022 Independent Non-Executive Director
Marcela V. Maus 48 2023 Member of Scientific Advisory Board
Avery Posey - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MXCT Price Commentary

Write your thoughts about MaxCyte Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email